Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

23 jun 2013 8:30 a.m. - 27 jun 2013 12:45 p.m.

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Session Chair(s)

Denise A. Calaprice-Whitty, PHD, MS

Denise A. Calaprice-Whitty, PHD, MS

Consultant

The Avoca Group, United States

Learning Objective : Describe the industry’s use of risk assessment methods, and in what ways they have been successful; Identify the different types of risk-sharing models being used and the successes and challenges of different approaches; Discuss risk-based management approaches.

Speaker(s)

Alistair  Macdonald, MS

Panelist

Alistair Macdonald, MS

Syneos Health, United States

Chair, ACRO; Chief Executive Officer

Mitchell A. Katz, PHD

Panelist

Mitchell A. Katz, PHD

Ferring Pharmaceuticals, United States

Vice President, Development Operations

Andy  Lee, MA

Panelist

Andy Lee, MA

Merck & Co., Inc., United States

Senior Vice President, Head of Global Clinical Trial Operations

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.